Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2025 Jan 31;20(1):e0293790. doi: 10.1371/journal.pone.0293790

Self-reported illnesses in Thatta: Evidence from a rural and underdeveloped district in Sindh province, Pakistan

Muhammad Ashar Malik 1,2,*, Rahat Batool 1, Muhammad Ahmed 3, Imran Naeem Abbasi 1, Zafar Ahmed Fatmi 1, Sarah Saleem 1, Sameen Siddiqui 1
Editor: Adnan Ahmad Khan4
PMCID: PMC11785293  PMID: 39888922

Abstract

Introduction

Self-reported illnesses (SRI) surveys are widely used as a low-cost substitute for weak Disease Surveillance Systems in low- and low-middle-income countries. In this paper, we report findings of a district-level disease prevalence survey of all types of illnesses including chronic, infectious, injuries and accidents, and maternal and child health in a rural district in Pakistan.

Methods

A district-level survey was conducted in Thatta in 2019 with a population-representative sample of all ages (n = 7811) a. Survey included questions on demographics and SRIs from the respondents. Prevalence was estimated for all SRIs categorized into six major and 16 minor illnesses. The influence of important socio-demographic covariates on the illnesses and multiple comorbidities was explored by estimating prevalence ratios with a Generalized Linear Model of the Poisson family and by Zero-Inflated Poison Distribution respectively.

Findings

36.57% of the respondents to the survey reported at least one SRI. Prevalence of communicable illnesses was 20.7%, followed by non-communicable illnesses (4.8%), Gastrointestinal disorders (4.4%), and injuries/disabilities (1.9%). Urban inhabitants were more likely to have Chronic Obstructive Pulmonary Disorders (3.34%) and Diabetes (1.62%). Females were most likely to have injuries (1.20,), disabilities (1.59), and Musculoskeletal Disorders (1.25). Children aged < 1 year (0.80) and elderly >65 years (0.78) were more likely to have comorbidities.

Discussion

Our estimated prevalence of SRI is quite higher than the prevalence of unknown SRIs in national-level surveys in Pakistan. This research’s findings serve as an example of aiding evidence-based priority settings within the health sector. Our findings on gender, and young and old age as positive predictors of SRI are consistent with similar surveys in a few LMICs.

Recommendation and conclusion

We provide evidence of a complete disease profile of a district that is otherwise unavailable in the country. This study can reshape the existing health surveys and to aid evidence-based priority settings in the health sector. We, however, support strengthening the Disease Surveillance System as a reliable source of disease prevalence data.

1. Introduction

Reliable data on the prevalence of illnesses is the first line of evidence on priority settings within the health sector. Health ministers of a country routinely maintain such data in their respective Disease Surveillance System and Disease Early Warning System. However, in Low- and Low-Middle Income Countries (LMICs) including Pakistan such practices are weak and unreliable [1,2]. Reliance on intermittent population health surveys is a common alternative in such situations in many LMICs. However, such surveys are costly and often held with the help of financial assistance from development partners. These surveys focus on maternal and child health and this aspect limits their use for priority setting within the health sector.

Disease Surveillance System and Disease Early Warning System are weak and unreliable in Pakistan [2]. The common sources of prevalence data are level population-level surveys using the methodology of self-reported illnesses. However, population surveys lack data on all types of illnesses and multiple comorbidities, for example, USAID funded Demographic and Health Survey (DHS), and UNICEF funded Multi Indicator Cluster Survey (MICS) collect illness prevalence data on maternal and child health needs and their infectious illnesses [3,4]. World Bank-assisted Pakistan Living Standard Measurement Survey (PSLM) collects illness prevalence data on maternal, and childhood diarrhoea and unknown self-reported illnesses [5]. Such features of these surveys limit their use for priority settings in the health sector that require evidence on all types of illnesses. Few other types of surveys conducted in Pakistan are illness-specific and lack representative data, for example, the National Diabetes Survey of Pakistan 2016–17 or the Adult Tobacco Survey 2014 [6,7]. In the situation of limited evidence on disease prevalence, priority settings of resource allocation to the health sector and among healthcare needs usually follow expert opinion or historical budgeting with a strong influence of the development assistance favouring maternal and child health. For example, a study using financing data from 2000–2010 indicated that on average the share of the maternal and child health sector was 21% of the total funds allocated in 2010 to the health sector in the country with a substantial component of development assistance (51% of total Official Development Assistance to health sector) to Pakistan [8]. With the devolution of many functions of health to lower tiers of the government, the role of the federal Ministry of Health is limited in priority setting in the health sector. On the other hand, the lower tiers of the health sector cannot collect and maintain disease prevalence data.

In 2017 a collaboration was established between the academia and the health district administration to prototype evidence-based priority settings for the health department of Thatta District. A district-level disease prevalence survey was planned in 2019, as a stepping stone to overcome the challenges of priority settings on expert opinion and following historical patterns. In this paper, we report the findings of the population representative illness survey in Thatta district. We provide prevalence estimates of all illnesses and their important socio-demographic covariates using the methodology of self-reported illnesses.

2. Methods

2.1 Survey settings

Thatta is an underdeveloped district in Sindh province in Pakistan. It is situated on the coastline of the Arabian Sea in the province of Sindh, Pakistan. In the census of 2023, the population of Thatta District was 1.083 million [9]. The male population was 52.1% and the population density was 100/km2. Over 80% of the population (approximately 0.98 million), lives in rural areas [9], and mainly relies on agriculture and fishing for their living. On the Human Development Index (HDI), it is ranked amongst the lowest: 90th out of 111 districts at the national level and 22nd among 23 districts in Sindh [10]. The health status and health-seeking patterns of the population are not so different from the HDI ranking of Thatta. For example, it was ranked among the highest in Sindh province in terms of under-five mortality (129 deaths per 10000 live births) and malnutrition (55%) and among the lowest for childhood vaccination (37% of children aged 1–2 years are fully immunized) [3,4]. Like the national situation, the illness profile of district Thatta is limited to maternal and child health, immunization, and unknown common illnesses.

2.2 Survey design and data collection

The sample size was devised assuming a design effect of 1.5, a standard deviation (PKR 15,300) of demand for healthcare in rural Sindh, a margin of error of 10%, and a 10% refusal rate. The final sample size of the survey was 1,060 households. Multistage cluster sampling was used with a stratification strategy. This sample was distributed through sampling proportionate to populations among sub-districts/Talukas (Stratum) of Thatta namely 1) Thatta, 2) Mirpur Sakro, 3) Keti Bundar, 4) Ghorabari and 5) Kharo Chann: the latter two being managed jointly. Each sub-district was divided into rural and urban domains (Pakistan Bureau of Statistics, 2020). Rural and urban classification was carried out using the definition of rural union council and urban wards by the district administration of Thatta district. The primary sampling units were obtained from the smallest administrative unit of the district/local government, that is Union Councils in rural areas and Wards in urban areas. Three primary sampling units (villages from Union Councils in rural areas and Mohallas/streets from Wards in urban areas) were selected at random in each UC/Ward. In each primary sampling unit, 8–12 households (secondary sampling units) were selected at random for data collection in the survey.

The survey questionnaire included demographic information and self-reported illness of every member of the household. Demographic data included age, gender, marital status, and schooling. Self-reported Illnesses included four categories: communicable illnesses (CIs) and non-communicable illnesses (NCIs), disabilities, and maternity and childbearing.

Data was collected by trained enumerators comprising a male and a female in each team. There were eight teams and a data collection supervisor. The data collectors were trained on data collection methods, cultural and religious sensitivities, the type and classification of illnesses, and the use of the computer tablet to enter data in the field. Data collection was completed over four months, from January 2019 to April 2019. Data was collected from 1396 households (8635 individuals).

Informed consent was obtained from all respondents. An informed consent form translated into the Sindhi language was provided to the respondents and in the case of the illiterate respondents were read out to them. Four households refused to participate in the survey, while 73 respondents called the principal investigator on phone/cell numbers provided in the consent form and enquired about the survey. They were provided with all the details they needed.

Female and male heads of the households were interviewed by the male and female members of the data collection teams respectively. Both heads of the household provided demographic data of their household members including age, gender, marital status, schooling, and so forth. Following these interviews, data from household members over the age of 12 were collected. The enumerators visited each household twice. In the morning the female enumerator interviewed the females present in the household, while in the afternoon the male enumerator interviewed the male members. Data from the members under the age of 12 years was collected from at least one of their parents but preferably their mothers. Data on SRI was collected using a recall and record basis. Prevalence of CIs was based on the past month recall, while the prevalence of NCIs and disabilities was based on the presence of illnesses at the time of the survey. For maternity and childbearing, the recall period was within the preceding 12 months. The record component of SRI data collection included viewing prescriptions, diagnostic tests, and/or medicine invoices by enumerators.

Data validation was done during and after the completion of the data collection process. During the data collection, the supervisory team visited the field site and verified data collected from randomly picked respondents. After the data collection, a data validation exercise was carried out by a researcher from the University not involved in data collection. A random sample from the villages and wards was selected and ten households were contacted by telephone and were asked to reconfirm data collected on five randomly picked questions of the questionnaire.

During the data cleaning process, we dropped four households and 824 members. After dropping missing and incomplete data, the final sample for analysis is 1392 households (7811 members). This sample was higher than the calculated sample size of 1060 households.

The survey underwent ethical review by the Aga Khan University Ethical Review Board. After reviewing the application, they provided approval (letter number 2018-0615-836 on 24 November 2018).

2.3 Analysis

Demographic and socio-economic characteristics are reported in means and proportions. Survey sampling techniques are included in all the estimates. Age classifications of the World Health Organization were used to group the respondent by their age [11].

For the policy-relevant presentations of our findings, we reclassified four categories of SRI into six major categories (Communicable Illnesses, Mental Health and Non-Communicable illnesses, Gastrointestinal and Liver disorders, Injuries and Disabilities, Gynaecological and Obstetrics Disorders, and others/unclassified Disorders). Additionally, there are sixteen minor categories (Malaria and other Febrile illnesses, Upper respiratory tract infections, Common Infectious illnesses, Tuberculosis, Chronic obstructive pulmonary illnesses, Hypertension, Ischemic heart illness & Stroke, Diabetes, Mental disorders, Diarrhoea, Typhoid and other GI problems, Cirrhosis/Chronic liver illness/Hepatitis, Disabilities, Injury/Accident, Arthritis/Musculoskeletal disorders, Gynaecology and obstetrics and others/unclassified). The prevalence of illnesses was estimated as a proportion of respondents that reported an illness among all respondents of the survey. We obtained Confidence Intervals of prevalence by normal approximation. Prevalence ratios were estimated to account for crucial exposure variables such as gender (except in gynecological disorders), age, and least developed areas. We defined Gorabari and Keti Bandar as the least developed Talukas as these were ranked lowest on socio-economic indicators among the four Talukas in Thatta District [12].

We used prevalence ratios to estimate the prevalence of SRI in Thatta District following the validation study on relative benefits and harms of odd ratios and risk ratios and prevalence ratios in cross-sectional studies by Tamhane and Westfall et al (2016) and Coutinho and Scazufca et al (2008) [13,14]. The prevalence ratios were estimated using Generalized Linear Models of the Poison family [14]. Prevalence ratios are preferred over odd ratios to overcome the problem of overestimation and difficulties in the convergence of the model [14] though we acknowledge the limitation of PR of not satisfying the property of reciprocity o PR for ill versus PR of healthy [13].

To analyze factors influencing the multiple SRIs (0–4) we estimated the coefficient for each covariate using a Zero-inflated Poisson Distribution by a Bayesian marginal likelihood function with Laplace- Metropolis approximation [15]. All analyses, data cleaning, and imputation were carried out in STATA 15.1 while data were downloaded in Excel spreadsheets.

3. Findings

The final sample of this survey is 1392 households (7811 individuals). Females were 48% (n = 3710) of the sample. The adult population was 58% of the sample. Most of the adults were married (62%) and illiterate (75%). One-third (30%) of adults were employed at the time of the survey. Most of the population in Thatta district was rural (81%) except for Thatta Taluka where rural inhabitation was 67%. The average literacy rate was 23% in Thatta District. Among talukas, the proportion of females was (50.14%), and employed (31.02%) in Keti Bander, literate (32.89%) and living in urban areas (32.81%) in Thatta Taluka, married (64.2%) in Mirpur Sakro Taluka was higher than other talukas and the district averages (Table 1).

Table 1. Socio-economic and demographic profile of survey respondents.

Talukas (Sub-districts)
 Indicators Thatta Mirpur Sakro Ghorabari Keti Bander District Thatta
Full sample 42.07 33.57 15.32 9.04 7811
Gender
    Male 52.8 52.54 53.47 49.86 52.6
    Female 47.2 47.46 46.53 50.14 47.5
Age
    Less than 1 year 3.59 3.33 3.43 3.69 3.48
    >1 and < = 5 13.3 14.15 13.47 14.49 13.73
    >5 and < = 16 28.67 30.3 31.97 29.4 29.81
    > 16 and < = 24 12.98 12.36 13.47 12.36 12.79
    >24 and < = 40 24.83 22.57 20.5 21.88 23.11
    >40 and < = 65 14.67 15.23 15.15 15.77 15.03
    65 years and above 1.97 2.07 2.01 2.41 2.05
Family size
    1–6 55.88 56.96 52.57 53.22 55.46
    7+ 44.12 43.04 47.43 46.78 44.54
Inhabitation
    Rural 67.19 89.7 96.07 86.67 80.93
    Urban 32.81 10.3 3.93 13.33 19.07
Adults sample (+15 years) 43.56 32.80 14.72 8.92 4539
Marital Status
    Married 61.46 64.2 62.13 62.96 62.41
    Single/unmarried 38.54 35.8 37.87 37.04 37.59
Literacy
    can read and write 32.89 16.37 13.66 17.37 23.26
    Can read 1.73 0.47 0.45 0.25 0.99
    Can write 1.02 0.2 - 0.25 0.53
    Neither can read nor can write 64.37 82.95 85.89 82.13 75.22
Employment
    Currently employed 30.44 30.38 27.78 31.02 30.08
    Unemployed but seeking employment 12.39 13.1 18.02 11.41 13.37
    Neither employed nor seeking employment 57.16 56.52 54.2 57.57 56.55

The sample pertains to all respondents of the survey. The adult population pertains to respondents who were aged 15 years and above at the time of collection of data.

Nearly 37% of the respondents reported at least one SRI: 21% communicable illnesses, 5% non-communicable illnesses, 4% gastrointestinal and liver illnesses, 2% injuries and disabilities, and 2% other illnesses, while 3% of the women of reproductive age reported pregnancy-related health care needs. Among all SRIs, Malaria/fever and flu/cough were the most common illnesses reported by the respondents (10%) followed by upper respiratory tract infections (9.98%) (Table 2).

Table 2. Illness prevalence in Thatta.

Types of Disorders No. Prevalence
Communicable Illnesses 1795 20.67%
19.3–22.1
    Malaria and other febrile illnesses 868 10.00%
8.9%-11%
    Upper respiratory tract infections 867 9.98%
8.9%-11%
    Common Infectious illnesses 36 0.41%
0.2%-0.6%
    Tuberculosis 24 0.28%
    0.1%-0.5%
NCI and Mental Health Disorders 414 4.77%
4%-5.5%
    Chronic obstructive pulmonary illnesses 103 1.19%
0.8%-1.6%
    Hypertension 108 1.24%
0.9%-1.6%
    Ischemic heart illness & Stroke 85 0.98%
0.6%-1.3%
    Diabetes 63 0.73%
0.4%-1%
    Mental disorders 55 0.63%
    0.4%-0.9%
Gastrointestinal and Liver Disorders 386 4.44%
3.7%-5.2%
    Diarrhoea, Typhoid, and other GI problems 284 3.27%
2.7%-3.9%
    Cirrhosis/Chronic liver illness/Hepatitis 102 1.17%
    0.8%-1.5%
Injuries and Disabilities 166 1.91%
1.4%-2.4%
    Disabilities 60 0.69%
0.4%-1%
    Injuries/Accidents 55 0.63%
0.4%-0.9%
    Arthritis/ Musculoskeletal disorders 51 0.59%
    0.3%-0.9%
Gynaecology and obstetrics 278 3.20%
    2.6%-3.8%
Other (unclassified) disorders 137 1.58%
    1.1%-2%
Total 3176 36.57%
    39.1%-42.4%

Prevalence is defined as the number of SRI (and by probing the respondents) in the respondents of the survey.

The estimated prevalence ratios revealed that being a female (PR 1.2, CIs 1.13–1.27), aged over 60 years (PR 1.54, CIs 1.41–1.69), and under five years (PR 1.42, CIs 1.33–1.52) are more likely to report an SRI. Living in urban areas (PR 1.51, CIs 1.42–1.61) and from least developed areas (PR 1.37, CIs 1.29–1.45) were more likely to report an SRI (Fig 1).

Fig 1. Rural and urban prevalence of self-reported illnesses in sub-districts of Thatta.

Fig 1

Subdistricts GB: Ghorabari, KB: Keti Bunder, MP: Mirpur Sakro, TA: Thatta, Disease Classification CD: Communicable Disease, NCD: Non-Communicable Diseases Mental Health Disorders, GI: Gastrointestinal & Liver Disorders, InDb: Injuries & Disabilities, OBG: Gynaecology & obstetrics, Mis: Other disorders.

Generally being employed (PR 0.83, CIs 0.75–0.91) and living in large/extended families (PR 0.7, CIs 0.66–0.74) decreased the likelihood of reporting and SRI in Thatta district. The prevalence ratios of Diabetes (PR 7.78, CIs 4.71–12.84) and Arthritis/musculoskeletal disorders (PR 4.91, CIs 2.55–9.47) in over 60 years were among the highest (Table 3).

Table 3. Illness prevalence ratios in Thatta in 2019.

Types of Disorders Female Over 60 years Under 5 years Literate Current employed Extended family Urban Least Developed Talukas
Communicable Illnesses 0.91 0.81 1.98 0.72 0.68 0.64 1.47 1.28
0.83–0.98 0.65–1.01 1.82–2.17 0.61–0.85 0.59–0.8 0.58–0.7 1.34–1.61 1.17–1.4
 Malaria and other febrile illnesses 0.89 0.69 1.89 0.75 0.67 0.65 1.44 1.30
0.78–1.02 0.48–0.99 1.65–2.18 0.58–0.95 0.53–0.84 0.57–0.75 1.24–1.66 1.13–1.5
 Upper respiratory tract infections 0.93 0.78 2.20 0.69 0.70 0.61 1.51 1.20
0.81–1.06 0.55–1.11 1.91–2.53 0.53–0.89 0.56–0.89 0.53–0.7 1.31–1.74 1.04–1.39
 Common Infectious illnesses 0.82 1.97 0.97 1.29 0.38 0.61 1.14 2.28
0.41–1.67 0.66–5.89 0.4–2.4 0.49–3.35 0.12–1.16 0.3–1.23 0.49–2.68 1.16–4.48
 Tuberculosis 0.88 3.78 0.00 0.43 1.20 1.21 1.48 2.34
0.38–2.05 1.39–10.28 0–0 0.09–1.96 0.39–3.63 0.52–2.86 0.55–3.99 1.08–5.07
NCI and Mental Health Disorders 1.13 4.18 0.50 1.64 1.04 0.84 2.00 1.83
0.92–1.37 3.36–5.2 0.35–0.71 1.3–2.07 0.81–1.35 0.69–1.02 1.63–2.44 1.5–2.24
 Chronic obstructive pulmonary illnesses 1.18 3.51 0.61 0.83 1.23 0.80 1.82 2.06
0.78–1.78 2.12–5.78 0.33–1.13 0.45–1.51 0.71–2.11 0.54–1.19 1.19–2.78 1.39–3.04
 Hypertension 1.89 4.62 0.07 2.53 1.28 0.97 3.11 1.63
1.26–2.85 3.03–7.04 0.01–0.48 1.67–3.81 0.77–2.1 0.66–1.42 2.12–4.57 1.05–2.53
 Ischemic Heart illness & Stroke 0.95 4.30 0.82 1.44 0.89 0.84 1.95 2.32
0.6–1.5 2.53–7.32 0.43–1.57 0.83–2.5 0.48–1.65 0.54–1.28 1.22–3.13 1.5–3.58
 Diabetes 0.76 7.78 0.14 2.28 1.24 0.75 1.17 1.38
0.44–1.31 4.71–12.84 0.02–1.04 1.29–4.02 0.68–2.23 0.45–1.27 0.64–2.12 0.78–2.44
 Mental disorders 0.83 1.17 0.67 1.15 0.49 0.81 1.64 1.62
0.49–1.43 0.41–3.31 0.31–1.44 0.5–2.62 0.19–1.27 0.48–1.39 0.92–2.92 0.93–2.8
Gastrointestinal and Liver Disorders 1.55 2.26 1.52 1.23 1.46 0.80 1.80 1.81
1.25–1.93 1.65–3.09 1.19–1.95 0.91–1.66 1.07–1.99 0.65–0.98 1.44–2.26 1.46–2.24
 Diarrhoea, Typhoid, and other GI problems 1.54 2.02 2.17 1.33 1.36 0.85 1.91 1.77
1.19–1.98 1.35–3.03 1.66–2.85 0.93–1.92 0.93–1.98 0.67–1.08 1.47–2.48 1.37–2.28
 Cirrhosis/Chronic liver illness/Hepatitis 1.60 2.74 0.17 1.04 1.68 0.67 1.50 1.91
1.02–2.51 1.61–4.66 0.05–0.53 0.59–1.83 0.94–2.98 0.44–1.01 0.93–2.42 1.25–2.92
Injuries and Disabilities 0.98 2.47 0.54 0.54 0.96 0.98 2.16 1.81
0.71–1.35 1.57–3.87 0.33–0.88 0.31–0.93 0.6–1.53 0.72–1.32 1.54–3.03 1.29–2.53
 Disabilities 0.59 1.37 0.72 0.55 0.47 1.14 1.45 0.69
0.35–1 0.53–3.5 0.36–1.45 0.21–1.4 0.19–1.15 0.69–1.87 0.82–2.57 0.35–1.35
 Injury/Accident 1.31 1.82 0.80 0.45 1.68 1.12 1.94 2.99
0.76–2.27 0.71–4.65 0.38–1.72 0.16–1.28 0.81–3.52 0.66–1.9 1.04–3.63 1.72–5.21
 Arthritis/ Musculoskeletal disorders 1.44 4.91 0.00 0.64 1.18 0.70 3.89 2.81
0.74–2.78 2.55–9.47 0–0 0.27–1.52 0.5–2.82 0.39–1.26 2.15–7.02 1.53–5.16
Gynaecology and obstetrics - - - 1.14 0.18 0.65 0.97 1.20
- - - 0.78–1.66 0.09–0.34 0.51–0.83 0.72–1.3 0.93–1.55
Other (unclassified) disorders 1.190 4.663 1.324 0.876 0.997 0.839 0.966 0.460
0.83–1.7 3.1–7.01 0.83–2.11 0.51–1.49 0.59–1.68 0.59–1.2 0.63–1.49 0.27–0.77
Being Ill 1.20 1.54 1.42 0.95 0.83 0.70 1.51 1.37
  1.13–1.27 1.41–1.69 1.33–1.51 0.87–1.04 0.75–0.91 0.66–0.74 1.42–1.61 1.29–1.45

Prevalence ratios are obtained as exponentiated coefficients (95% confidence intervals in parenthesis) of a generalized linear model for the Poisson family with a logarithmic link function. The exposure variables include being a female (except Gynaecology and obstetrics), age categories, being literate (can read and write), living in an extended family, living in urban areas, and living in least developed talukas (Kati-Bandar or Ghorabari).

The socio-demographic factors that determined the multiple SRIs were similar to the factors determining a single SRI, except for the gender of the respondents. Being a female decreases the probability of multiple morbidities (Regression Mean -0.16, CIs -0.29- -0.04) in Thatta district. Living in an urban area increased the probability of multiple morbidities (Regression Mean 0.42, CIs 0.3–0.51) followed by living in the least developed areas (Regression Mean 0.29, CIs 0.15–0.41) whereas being currently employed and living in an extended family decreased the probability of multiple morbidities by 23% and 22% respectively (Table 4).

Table 4. Determinants of multiple morbidities (0–4) in Thatta in 2019.

Determinants Mean (95% Equal tailed Creditable Intervals)
Female -0.16
-0.29- -0.04
Under 5 years 0.18
0.05–0.35
Over 60 years 0.13
-0.03–0.27
Urban 0.42
0.3–0.51
Literate -0.170
-0.43–0.06
Currently employed -0.23
-0.36–0.1
Extended family -0.22
-0.32–0.11
Least developed Talukas 0.29
0.15–0.41
BIC 12342.34
Sample 4254

Sample pertains to respondents of self-reported illnesses: Healthy and or having 1–4 illnesses. Estimates are obtained with a Bayesian zero-inflated Poisson regression using a Marginal likelihood (ML) by Laplace-Metropolis approximation. BIC is the Bayesian information criterion.

4. Discussions

In this study, we report the prevalence of illnesses including communicable illnesses, non-communicable illnesses, injuries/accidents, and maternity-related illnesses. To the best of our knowledge, the most recent such effort before our study is the National Health Survey which reported the complete disease profile of Pakistan in 1994–95 using burden of disease methodology [16]. We went a step ahead by explaining risk factors of the prevalence of illnesses and comorbidities that were not reported in national/provincial surveys including the National Health Survey 1994. Nevertheless, there are certain limitations to the interpretation of the results. Firstly, this survey was a rapid cross-sectional survey conducted in the spring and did not capture seasonal variation in the prevalence of illness. Secondly, findings on the prevalence of illness were validated with records, there was no clinical examination conducted during the data collection. Thirdly, we preferred PRs over ORs to overcome the problem of overestimation, but we acknowledge the limitations of PR that the property of reciprocity is not observed for PR for exposed/ill versus PR for unexposed/healthy [13]. Lastly, the estimated prevalence of a few illnesses is alarmingly low such as Diarrhoea, typhoid, and other GIs. One possible explanation for such low prevalence is that the survey was conducted in winter/spring. Another case is a low prevalence of NCI which could the to the lack of clinical examination for reporting an illness.

Estimates of the lone Burden of Disease study by the Pakistan Medical Research Council, in 1994 for NCIs (37.7%) and CI (38.4%) [16] were comparable, whereas in our case prevalence of CIs (20.67%) was higher than the prevalence of NCIs (6.68%, including injuries and disabilities 1.91%) in Thatta. These findings could partly be due to the illness classification used in our study and partly since our sample pertains to Thatta district which is the least developed district in Pakistan while the Burden of Disease study was drawn from a nationally representative sample. Our findings on the prevalence of SRIs (36.57%) in Thatta are higher than the national prevalence of unknown SRIs (7.38%) using a recall period of two weeks Pakistan Living Standard Measurement Surveys 2019–20 [5]. On the other hand, disability prevalence in our study is lower (0.7%) than disabilities reported in Thatta (3.01%) in PSLM 2019–20 [5]. We can speculate that such differences are due to differences of sample size, survey design effects, timing of survey, and recall methods.

We find few studies reporting the prevalence of illnesses using SRI approach and mainly LMICs from Latin America, Asia, and African contents, for example, Colombia [17], Vietnam [18,19], Botswana [20], Nepal [21], Bangladesh [22], Myanmar [23], Uganda [24] and Cambodia [25]. A possible explanation for the popularity of SRI surveys is weak disease surveillance systems in many LMICs [26]. Moreover, population health surveys are expensive and conducted with financial assistance from development partners and follow their priorities, often restricted to infectious illnesses and maternal and child health such as Living Standard Surveys sponsored by the World Bank, Multi-Indicator Cluster Surveys by UNICEF, and Demographic and Health Surveys by the USAID [35]. However, using the common methodology in these surveys enables comparison across countries while in the case of SRI surveys, the methods varied across countries for the type of illnesses, recall period, and geographical focus making the comparison of results challenging. For example, some SRI surveys were carried out on a small scale covering all types of illnesses in Vietnam, Cambodia, Bangladesh, and Nepal [18,21,22,25]. Few studies of SRIs used common recall for NCIs and CIs [18,21,22,25] and acute/communicable illnesses survey by SeoAung and MyintOo et al (2015) used a 90 days recall period [23]. Illness surveys that focused on NCIs enquired about illnesses based on “ever diagnosed/ informed by a physician or health worker” [17,19,20,24,27]. Except for Rehman and Gilmour et al, (2013), the SRI surveys included all illnesses and were conducted in rural areas [18,21,25]. Surveys on NCI, on the other hand, were carried out in urban areas [23] or were conducted at a larger scale [17,20,27].

Estimates of SRI in this paper (36.6%) are lower than the estimates of SRI in Bangladesh [22] (45%, n = 1593 households), and SRIs estimates in Vietnam (47.7%, n = 48919), but higher than SRIs estimates in Cambodia (15.05%, n = 33161) (Ir and Men,2010) and in Nepal (24.5%, n = 6580) [19,21,25]. These studies used a rapid data collection: 3–4 months and focused on all ages and all illnesses. However, the recall period in the case of Giang and Allebeck (2003), Rehman and Gilmour (2013), and Paudel (2020) was the previous four weeks, while in the case of Ir and Men (2010), the recall period was the previous one year [18,21,22,25]. Moreover, in the case of Ir and Men (2010) the SRI data was collected by trained data collectors and was verified by a public health doctor while in the case of Giang and Allebeck (2003), Rehman and Gilmour (2013) such steps of enhancing quality of data collection were missing [18,22,25]. Such variation in survey design may have influenced the prevalence of an illness. For example, diabetes prevalence was found to be as low as 1.1% in Uganda, 5.7% in Colombia, and 9.3% (metabolic illnesses) in India [17,24,28]. While in Colombia and India, the sample size was large: 11 districts and country level respectively, in Uganda, the study was carried out in an urban district [17,24,28]. The period of data collection spanned over one year in Colombia and India [17,28]. In Uganda and Colombia, the sample was drawn from the adult population, and in India, the sample included all ages [24,28].

Our findings on the risk factors (age, gender, and residential status) of SRI or comorbidities with literature included in this paper. Our finding that women are more likely to report illness(es) and multiple morbidities is consistent with findings from Colombia, Vietnam, Cambodia, Nepal, Myanmar, Botswana, India, Bangladesh, and Uganda [17,2025,28].

Our findings on the role of old age (aged 60 years and above) reporting SRIs or NCIs, is consistent with findings from Colombia, Myanmar, Botswana, Bangladesh, and Vietnam [17,18,20,22,23].

Our findings that living in urban areas increases the prevalence of SRIs over living in rural areas are consistent with similar findings from Colombia, Botswana, and India [17,20,28]. On unemployment as a predictor of comorbidities, our findings are similar to findings from Vietnam: higher likelihood of NCIs for unemployed than employed (OR 1.59, CIs 0.96–2.69) [19] whereas on household size our findings are similar to findings from Bangladesh (OR 0.89, CIs 0.82–0.87) and India reporting a decreasing proportion of illnesses with increasing family size (<4 members 26.8, 5–8 members 26.0% and >9 members 20.2%) [22,28].

5. Recommendations and conclusion

For multiple reasons, our estimates are better than the existing evidence of illness prevalence in Pakistan. We recommend that the policymakers advocate for replacing unknown self-reported illnesses with descriptions of all types of illnesses in the PSLM survey. Similarly, district health administrations in other provinces in Pakistan can replicate our survey for evidence-based decision-making within their respective districts. However, we conclude that strengthening the Disease Surveillance System and Disease Early Warning System are crucial elements for evidence-based priority settings in the health sector at national and sub-national levels in Pakistan.

Acknowledgments

We gratefully acknowledge the survey’s field staff for their contributions and the district health office officials, Thatta, for their logistical support.

Data Availability

We cannot share data publicly because of legal and ethical restrictions. We have committed with the respondents of the survey at the time of singing consent form on confidentiality of personal information that are not to be shared with any third party. Same commitment has been made in the ethical review application." However, we can consider individual request for accessing data by writing to zaheer.habib@aku.edu Senior Manager, Data Management Unit, Community Health Sciences Department, Aga Khan University.

Funding Statement

This study was funded by the World Health Organization (WHO Registration Grant No.: 2018/824227-0; Purchase Order: 202084766). This grant was received by Dr. Sameen Siddiqui.

References

  • 1.Phalkey RK, Yamamoto S, Awate P, Marx M. Challenges with the implementation of an Integrated Disease Surveillance and Response (IDSR) system: systematic review of the lessons learned. Health policy and planning. 2015. Feb 1;30(1):131–43. doi: 10.1093/heapol/czt097 . [DOI] [PubMed] [Google Scholar]
  • 2.Shaikh TG, Waseem S, Ahmed SH, Swed S, Hasan MM. Infectious disease surveillance system in Pakistan: challenges and way forward. Tropical Medicine and Health. 2022. Jul 19;50(1):46. doi: 10.1186/s41182-022-00439-y . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.National Institute of Population Studies (NIPS) Pakistan and ICF. Pakistan Demographic and Health Survey 2017–18. Available from: https://dhsprogram.com/publications/publication-fr354-dhs-final-reports.cfm National Institute of Population Studies Pakistan and ICF. 2019. [Google Scholar]
  • 4.Sindh Bureau of Statistics. Multiple Indicators Cluster Survey Sindh. Available from: https://sbos.sindh.gov.pk/multiple-indicator-cluster-survey-mics. Government of Sindh. 2015. [Google Scholar]
  • 5.Pakistan Bureau of Statistics. Pakistan Social and Living Standard Measurement Survey 2019–20. Available from: https://www.pbs.gov.pk/publication/pakistan-social-and-living-standards-measurement-survey-pslm-2019-20-provincial. Government of Pakistan; 2020. [Google Scholar]
  • 6.Basit A, Fawwad A, Qureshi H, Shera AS. Prevalence of diabetes, pre-diabetes and associated risk factors: second National Diabetes Survey of Pakistan (NDSP), 2016–2017. BMJ open. 2018. Aug 1;8(8):e020961. doi: 10.1136/bmjopen-2017-020961 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Saqib MA, Rafique I, Qureshi H, Munir MA, Bashir R, Arif BW, Bhatti K, Ahmed SA, Bhatti L. Burden of tobacco in Pakistan: findings from global adult tobacco survey 2014. Nicotine and Tobacco Research. 2018. Aug 14;20(9):1138–43. doi: 10.1093/ntr/ntx179 . [DOI] [PubMed] [Google Scholar]
  • 8.Malik MA, Nahyoun AS, Rizvi A, Bhatti ZA, Bhutta ZA. Expenditure tracking and review of reproductive maternal, newborn and child health policy in Pakistan. Health policy and planning. 2017. Jul 1;32(6):781–90. doi: 10.1093/heapol/czx021 . [DOI] [PubMed] [Google Scholar]
  • 9.Pakistan Bureau of Statistics. Population and Housing Census 2023 ‘The Digital Census’ Results. Available from: https://www.pbs.gov.pk/content/announcement-results-7th-population-and-housing-census-2023-digital-census. Government of Pakistan. 2023. [Google Scholar]
  • 10.United National Development Program. Pakistan Human Development Index Report 2017. Available from: https://www.undp.org/sites/g/files/zskgke326/files/migration/pk/HDI-Report_2017.pdf Khursheed Printers. 2017. [Google Scholar]
  • 11.World Health Organization. Regional Health Observatory—Southeast Asia. Age Group Code list. Available online https://apps.who.int/gho/data/node.searo-metadata.AGEGROUP. [Google Scholar]
  • 12.Rural Health Programme. Public Health Practice, Community Health Sciences MC, Pakistan. Available online https://www.aku.edu/mcpk/chs/Pages/rural-health-programme.aspx. The Aga Khan University; 2018. [Google Scholar]
  • 13.Tamhane AR, Westfall AO, Burkholder GA, Cutter GR. Prevalence odds ratio versus prevalence ratio: choice comes with consequences. Statistics in medicine. 2016. Dec 30;35(30):5730–5. doi: 10.1002/sim.7059 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Coutinho L, Scazufca M, Menezes PR. Methods for estimating prevalence ratios in cross-sectional studies. Revista de saude publica. 2008; 42:992–8. 10.1590/S0034-89102008000600003. [DOI] [PubMed] [Google Scholar]
  • 15.Green JA. Too many zeros and/or highly skewed? A tutorial on modelling health behaviour as count data with Poisson and negative binomial regression. Health Psychology and Behavioral Medicine. 2021. Jan 1;9(1):436–55. PMCID: PMC8159206. doi: 10.1080/21642850.2021.1920416 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Pakistan Medical Research Council. National Health Survey of Pakistan. In Health profile of the people of Pakistan– 1990–94 Islamabad: Network Publication Service. 1998. [Google Scholar]
  • 17.Camacho PA, Gomez-Arbelaez D, Otero J, González-Gómez S, Molina DI, Sanchez G, et al. Self-reported prevalence of chronic non-communicable diseases in relation to socioeconomic and educational factors in Colombia: a community-based study in 11 departments. Global Heart. 2020;15(1). doi: 10.5334/gh.792 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Giang KB, Allebeck P. Self-reported illness and use of health services in a rural district of Vietnam: findings from an epidemiological field laboratory. Scandinavian journal of public health. 2003. Dec;31(62_suppl):52–8. doi: 10.1080/14034950310015112 . [DOI] [PubMed] [Google Scholar]
  • 19.Van Minh H, Long KQ, Ha NT, Duong DT, Trung T, Huong HT, et al. Self-reported non-communicable diseases and associated socio-demographic status among ethnic minority populations in Vietnam, 2019. Health Psychology Open. 2020. Sep;7(2):2055102920954707. doi: 10.1177/2055102920954707 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Letamo G, Keetile M, Navaneetham K, Phatsimo M. Prevalence and correlates of self-reported chronic non-communicable diseases in Botswana: a cross-sectional study. International Health. 2017. Jan 1;9(1):11–9. doi: 10.1093/inthealth/ihw052 . [DOI] [PubMed] [Google Scholar]
  • 21.Paudel DR. Determinants of Self-Reported Illness: An Experience from Social Health Insurance Program in Nepal. Nepalese Journal of Insurance and Social Security. 2020. Dec 1;3(3):1–22. [Google Scholar]
  • 22.Rahman MM, Gilmour S, Saito E, Sultana P, Shibuya K. Self-reported illness and household strategies for coping with health-care payments in Bangladesh. Bull World Health Organ. 2013. Jun 1;91(6):449–58. PMCID: PMC3777143. doi: 10.2471/BLT.12.115428 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Aung MS, Oo WM, Lwin KT, Maung TM. Health Services Utilization and Self-Reported Acute Illnesses among Urban Families Inthanlyin Township, Yangon Region,Myanmar. Available from https://meral.edu.mm/record/3171/file_preview/PSM%2014.pdf?allow_aggs=True Doctoral dissertation, MERAL Portal. [Google Scholar]
  • 24.Siddharthan T, Kalyesubula R, Morgan B, Ermer T, Rabin TL, Kayongo A, Munana R, Anton N, Kast K, Schaeffner E, Kirenga B. The rural Uganda non-communicable disease (RUNCD) study: prevalence and risk factors of self-reported NCDs from a cross-sectional survey. BMC Public Health. 2021. Dec; 21:1–8. 10.1186/s12889-021-12123-7 PMCID: PMC8572568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ir P, Men C, Lucas H, Meessen B, Decoster K, Bloom G, et al. Self-reported serious illnesses in rural Cambodia: a cross-sectional survey. PloS one. 2010. Jun 3;5(6):e10930. PMCID: PMC2880606. doi: 10.1371/journal.pone.0010930 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Phalkey RK, Yamamoto S, Awate P, Marx M. Challenges with the implementation of an Integrated Disease Surveillance and Response (IDSR) system: systematic review of the lessons learned. Health policy and planning. 2015. Feb 1;30(1):131–43. doi: 10.1093/heapol/czt097 . [DOI] [PubMed] [Google Scholar]
  • 27.Van Minh H, Ng N, Juvekar S, Razzaque A, Ashraf A, Hadi A, et al. Self-reported prevalence of chronic diseases and their relation to selected sociodemographic variables: a study in INDEPTH Asian sites, 2005. Preventing chronic disease. 2008;5(3): A86. PMCID: PMC2483549. [PMC free article] [PubMed] [Google Scholar]
  • 28.Vellakkal S, Subramanian SV, Millett C, Basu S, Stuckler D, Ebrahim S. Socioeconomic inequalities in non-communicable diseases prevalence in India: disparities between self-reported diagnoses and standardized measures. PloS one. 2013. Jul 15;8(7): e68219. PMCID: PMC3712012. doi: 10.1371/journal.pone.0068219 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Adnan Ahmad Khan

12 Dec 2023

PONE-D-23-33013Self-reported illnesses in Thatta: Evidence from a rural and underdeveloped district in Sindh province, PakistanPLOS ONE

Dear Dr. Malik,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Detailed comments, by reviewers and editors are appended below. We look forward to receiving your revised manuscript.

Please submit your revised manuscript by Jan 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Adnan A. Khan

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“We gratefully acknowledge the World Health Organization, Regional Office, Eastern Mediterranean Region for providing funding for this survey. Our acknowledgments are due to the field staff of the survey for their contributions to the survey and to the officials of the district health office, Thatta for their logistic support.”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“World Health Organization regional office of the Eastern Mediterranean Region supported this survey”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

6. Please amend your manuscript to include your abstract after the title page.

7. Please include a separate caption for each figure in your manuscript.

8. We note that Figure 1 in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

9. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

Additional Editor Comments:

This is an interesting study which has potential to inform healthcare utilization. However, as pointed out by reviewers, major and substantial revisions are needed before it can be accepted for publication. In addition to specific comments, including those in the manuscripts by Reviewer 2, the authors may consider the following:

While the authors suggest the use of SRI to direct priorities in health systems, essentially an exercise in burden of disease estimation, the data presented does not support this assertion. The term "burden of disease" is repeatedly mentioned. Instead it would be more accurate to use this data to understand what communities are feeling in terms of symptoms/ disease self perceptions and use this information to improve healthcare provision. If this was the intent, please carefully re word to communicate this.

Some claims such as "our estimates of burden of disease are much higher and comprehensive than the current evidence of health seeking in Thatta" (Discussion section in abstract), need to be backed with evidence. What are the study findings being compared against. Are there BoD or healthcare seeking estimates from Thatta available. Is it the same or different in public and private sector?

In the introduction section, there is a need to elaborate why SRI framework was used, its applicability and limitations to the context of the study. Mention of low capacity by district adminstrators needs to be both elaborated upon and also corroborated with evidence

There is a need to copy edit final version before submission to avoid simple grammar and word ommission errors

Methods:

The survey and sampling design is well described.

It must be specified how many interviews were conducted per HH, specifically, if the husband and wife were both interviewed or one interviewee per HH was selected. If latter there should be analysis of the effect of this designation on the results

It should also be highlighted that answers for children are from their parents and therefore not "self reported".

Verban autopsy is mentioned in the discussion as a means to verify self reports. The methodology used is not mention. There is no mention of verbal autopsy in results either

Line 90 mentions two methods of verification were used. Please specify #2. Were any statistical means used to measure verification?

Assumptions of prevalence ratio methodology used may be discussed

Results:

Table 2 suggests that the prevalences are for the entire year, please confirm. The period for which self reported illnesses were asked for is not specified

Table 2 describes prevalences. Some of these vary widely (log order differences) than national figures. For example, Hypertension of 1.24%, Diabetes: 0.73% compare with national figures of 30-50% and 17-26% respectively. There is a need to discuss these differences and their posited rationale. Diarrhea is reported at 3.27% for the year, when PSLM data suggests around 16% in 2 weeks prior to survey

Table 4 may benefit from the use of continuous age variable. Otherwise there is concern that some of the lower morbidity among women may actually be a cohort effect (women are often younger than men in surveys, whether this is true or not must be mention)

Verbal autopsy (mentioned in discussion, line 159) is not mentioned in results

Discussion:

There needs be a discussion of log order lower prevalence of many common conditions in this survey compared to the national samples. The assertion that prevalences are "alarmingly high" (line 154) is not corroborated by national data

While the discussion of SRI literature (likely better placed in introduction) is extensive, it needs to clarify what is intended with this review and how this review serves this study

SRI data presented has not been validated and can not be used to estimate about burden of disease

Unclear what is meant with unknow SRI (lines 199-201)

While there is extensive citing of literature in discussion, it may be supplemented by interpreting the findings AND THEN connect this interpretation to the cited literature

In Recommendations, it is suggested that a combined SRI type survey may substitute for individual disease survey. This is not justified based on the data presented. If anything the data suggests that SRI may massively under identify serious conditions

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This research titled as "Self-reported illnesses in Thatta: Evidence from a rural and underdeveloped district in Sindh province, Pakistan" lacks a strong conceptual foundation. The study's premise relies on a superficial analysis of existing literature, failing to adequately highlight any discernible literature gap. An effective study typically builds upon existing research by identifying gaps or unexplored areas, contributing valuable insights to the field. However, regrettably, this manuscript appears to fall short in this regard.

The absence of a clear identification of the literature gap significantly diminishes the scholarly impact of this work. A comprehensive understanding of existing research is fundamental to conducting a meaningful study, enabling the identification of areas where new knowledge can be generated. Unfortunately, this manuscript fails to provide such a distinctive contribution to the established body of knowledge in its respective field.

For a study to be considered robust and impactful, it should not only engage with relevant literature but also delineate how it extends or challenges existing knowledge. This manuscript, regrettably, does not adequately fulfill this criterion. Hence, it may not significantly advance the field or offer novel perspectives, rendering it less impactful in contributing to the discourse within the academic realm.

Reviewer #2: I have completed a thorough review of your manuscript titled "Self-reported illnesses in Thatta: Evidence from a rural and underdeveloped district in Sindh province, Pakistan." I commend the effort you have invested in your research, and I recognize the importance of the manuscript's topic. However, I must convey that, upon careful examination, the manuscript requires significant revisions before it can advance further in the processing stage.

The manuscript faces challenges in terms of clarity in several sections, making it difficult for readers to seamlessly follow the content. I suggest considering a restructuring of sentences and paragraphs to enhance overall coherence.

Numerous grammatical errors and language issues were identified throughout the manuscript. To improve the overall quality of the writing, I recommend a thorough language editing process.

The references require careful attention, as some instances deviate from the journal's prescribed reference guidelines. It is essential to ensure adherence to the specified format for all references.

Furthermore, a comprehensive and well-articulated conclusion is currently lacking. I encourage you to summarize your key findings and discuss their implications, providing a strong closing statement for the manuscript.

Additionally, it is important to note that I could not review the tables in their entirety, as they were not present in the submitted file. I kindly request that you ensure the inclusion of tables in your revised submission, enabling a comprehensive review of all elements of the manuscript.

Your attention to these revisions will significantly contribute to the overall quality and readiness of your manuscript for further processing. Please see the attached manuscript for my detailed comments.

Reviewer #3: It would be good to reviewdata tables for easier understanding of key findings. Tables were not available in the manuscript, however, reference to tables is given. Maybe there is an error in uploading / downloading.

Tone of some sentences may be corrected, e.g. rather than "illetrate" it would be better to use the word un-educated.

Since the study focuses on just one district, it should be mentioned as a limitation of the study.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Imran Hameed Khaliq

Reviewer #3: Yes: Naeem Majeed

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-23-33013.pdf

pone.0293790.s001.pdf (1.2MB, pdf)
PLoS One. 2025 Jan 31;20(1):e0293790. doi: 10.1371/journal.pone.0293790.r002

Author response to Decision Letter 0


25 Jul 2024

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

We have provided details of participants consent and data collection process in details in the methods section of the revised manuscript.

3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match.

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

The grant information is appended below and have been added in both sections

The details of WHO Registration Grant No.: 2018/824227-0, Purchase Order: 202084766, Amount: USD 50K.

4. Thank you for stating the following in the Acknowledgments Section of your manuscript:

“We gratefully acknowledge the World Health Organization, Regional Office, Eastern Mediterranean Region for providing funding for this survey. Our acknowledgments are due to the field staff of the survey for their contributions to the survey and to the officials of the district health office, Thatta for their logistic support.”

We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form.

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows:

“World Health Organization regional office of the Eastern Mediterranean Region supported this survey”

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

Reply: The acknowledgement section is edited according to the editor’s advice.

5. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For more information on unacceptable data access restrictions, please see http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions.

In your revised cover letter, please address the following prompts:

a) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories.

We will update your Data Availability statement on your behalf to reflect the information you provide.

Reply: We cannot share data publicly because of legal and ethical restrictions. We have committed with the respondents of the survey at the time of singing consent form on confidentiality of personal information that are not to be shared with any third party. Same commitment has been made in the ethical review application." However, we can consider individual request for accessing data by writing to zaheer.habib@aku.edu Senior Manager, Data Management Unit, Community Health Sciences Department, Aga Khan University.

6. Please amend your manuscript to include your abstract after the title page.

Reply: Abstract is appended after the title page.

7. Please include a separate caption for each figure in your manuscript.

8. We note that Figure 1 in your submission contains [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

a. You may seek permission from the original copyright holder of Figure 1 to publish the content specifically under the CC BY 4.0 license.

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

b. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

We used ArcMap software version10.8 licensed to NED University, Karachi, Pakistan to develop figure 1. The data utilized in this figure is not sourced from proprietary sources (whatsoever) such as Google Maps, Street View, or Earth.

This statement is now appended in the notes below figure 1

9. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate "supporting information" files

We have included tables in the main text.

Additional Editor Comments:

This is an interesting study which has potential to inform healthcare utilization. However, as pointed out by reviewers, major and substantial revisions are needed before it can be accepted for publication. In addition to specific comments, including those in the manuscripts by Reviewer 2, the authors may consider the following:

While the authors suggest the use of SRI to direct priorities in health systems, essentially an exercise in burden of disease estimation, the data presented does not support this assertion. The term "burden of disease" is repeatedly mentioned. Instead, it would be more accurate to use this data to understand what communities are feeling in terms of symptoms/ disease self perceptions and use this information to improve healthcare provision. If this was the intent, please carefully re word to communicate this.

We have removed the term burden of disease from the revised version of the manuscript and consistently used the term self-reported illnesses.

Some claims such as "our estimates of burden of disease are much higher and comprehensive than the current evidence of health seeking in Thatta" (Discussion section in abstract), need to be backed with evidence. What are the study findings being compared against. Are there BoD or healthcare seeking estimates from Thatta available. Is it the same or different in public and private sector?

We have added estimated prevalence of certain illnesses reported in national and provincial surveys to clarify our comparison.

In the introduction section, there is a need to elaborate why SRI framework was used, its applicability and limitations to the context of the study. Mention of low capacity by district adminstrators needs to be both elaborated upon and corroborated with evidence.

We have provided limitation of SRI. We have provided reference to our claims of low capacity of district administrators.

There is a need to copy edit final version before submission to avoid simple grammar and word omission errors.

We have reviewed our revised manuscript by an native English speaking scholar.

Methods:

The survey and sampling design is well described.

It must be specified how many interviews were conducted per HH, specifically, if the husband and wife were both interviewed or one interviewee per HH was selected. If latter there should be analysis of the effect of this designation on the results

It should also be highlighted that answers for children are from their parents and therefore not "self-reported".

We mentioned the process of data collection from children below 2 years of age in paragraph 3 of Survey Design and Data Collection.

Verban autopsy is mentioned in the discussion as a means to verify self-reports. The methodology used is not mentioned. There is no mention of verbal autopsy in results either.

We removed the term “verbal autopsy” and provided more details on methods of collection data from the respondents.

Line 90 mentions two methods of verification were used. Please specify #2. Were any statistical means used to measure verification?

We specified two methods of verification, during the data collection and after the data collection in the revised manuscript in the second last paragraph of section on Survey Design and Data Collection.

Assumptions of prevalence ratio methodology used may be discussed.

We provided limitations of prevalence ratios in the first paragraph of the discussion section and cited some literature in support of it. However, this is not a study on validating methods of reporting risk factors/ covariates of SRIs, but we can redo the analysis using odd ratios if the reviewer may wish.

Results:

Table 2 suggests that the prevalences are for the entire year, please confirm. The period for which self-reported illnesses were asked for is not specified.

We have provided the period of data collection in paragraph 3 of section on data collection. We also corrected the heading of table 2.

Table 2 describes prevalences. Some of these vary widely (log order differences) than national figures. For example, Hypertension of 1.24%, Diabetes: 0.73% compared with national figures of 30-50% and 17-26% respectively. There is a need to discuss these differences and their posited rationale. Diarrhea is reported at 3.27% for the year, when PSLM data suggests around 16% in 2 weeks prior to survey.

We have provided such comparisons in the discussion section and the challenges making such comparisons.

Table 4 may benefit from the use of continuous age variable. Otherwise, there is concern that some of the lower morbidity among women may be a cohort effect (women are often younger than men in surveys, whether this is true or not must be mention)

The mean age difference between males in females was 0.34 years so we don’t anticipate such bias introduced in the model. Moreover, we included >5 years and<60 years purposefully learning from literature about greater healthcare need such as Malik and Azam, 2012. (Muhammad Malik, A., & Azam Syed, S. I. (2012). Socio-economic determinants of household out-of-pocket payments on healthcare in Pakistan. International journal for equity in health, 11, 1-7.)

Verbal autopsy (mentioned in discussion, line 159) is not mentioned in results.

We have removed the term verbal autopsy from the methods section and have provided more details in the section on methods of data collection.

Discussion:

There needs be a discussion of log order lower prevalence of many common conditions in this survey compared to the national samples. The assertion that prevalences are "alarmingly high" (line 154) is not corroborated by national data

We have edited this argument that comparison with national survey is not possible because of difference in age cohort focused in these surveys.

While the discussion of SRI literature (likely better placed in introduction) is extensive, it needs to clarify what is intended with this review and how this review serves this study

The objective of this review is to advocate the challenges with comparison of estimates of SRIs due to difference in survey design, period, geographical coverage, methods of analysis and data collection.

SRI data presented has not been validated and cannot be used to estimate about burden of disease

We mentioned this limitation in the revised manuscript.

Unclear what is meant with unknow SRI (lines 199-201)

We replaced “unknown” with “other” SRI

While there is extensive citing of literature in discussion, it may be supplemented by interpreting the findings AND THEN connect this interpretation to the cited literature

In Recommendations, it is suggested that a combined SRI type survey may substitute for individual disease survey. This is not justified based on the data presented. If anything, the data suggests that SRI may be massively under identify serious conditions.

In the revised manuscript, we did provide interpretation of our results from other sources in Pakistan and next we compare our findings with literature outside Pakistan.

We

Attachment

Submitted filename: ReviewreportPLOSone23.docx

pone.0293790.s002.docx (28.2KB, docx)

Decision Letter 1

Adnan Ahmad Khan

11 Sep 2024

PONE-D-23-33013R1Self-reported illnesses in Thatta: Evidence from a rural and underdeveloped district in Sindh province, PakistanPLOS ONE

Dear Dr. Malik,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 26 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Adnan Ahmad Khan

Academic Editor

PLOS ONE

Additional Editor Comments:

Thank you for the revisions that have clarified some of the measurement and findings. I would like to draw your attention to the Introduction and Discussion sections and ask for clarity in what is being conveyed. Following are some issues to address:

1. In the Introduction section, it is unclear what is the point of this study. Is it intended as an alternative to current BoD surveys and modeling? If so a connection must be made to BoD literature, confluence points and why this study would add to the knowledge base

2. In the Introduction section, it is unclear what is the point of Para on pg 4 from line 81

3. In the Findings section, it appears that for acute/transient illnesses, only the past two weeks period is included. This would mean different things if extrapolated for an entire year or to the community as a measure of burden of SRI. Please clarify what is the denominator and if you are intending a point in time prevalence or is it for the year - and what adjustments/ analyses would be needed for each

4. In the Discussion section, the first sentence is unclear. What example does the study set. It should be clarified what is the value of this information and how does it enhance the knowledge in the field. Ideally one would like to see an framework where findings of this study can be linked to BoD. Also, the discussion section should open by positing what the study has shown and what salient findings would be discussed.

5. The subsequent paras in the Discussion attempt to explain the findings in the schema: SRI, then NCI, but the discussion goes back and forth with circling back to points. Better organization and flow of logic would help understand the message.

6. Some parts of the narrative are unclear. For e.g., the sentence on Line 307 in unclear. What could not be synthesized. Prevalence with measures of variation should be available in the data collected. Is there a desire to compare these to literature. This is not clear.

7. Better overall structuring of the narrative in Intro and Discussions with attention to flow of logic would help

The study has potential for an important contribution to the body of knowledge on the subject, but would require substantial re-writing

[Note: HTML markup is below. Please do not edit.]

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2025 Jan 31;20(1):e0293790. doi: 10.1371/journal.pone.0293790.r004

Author response to Decision Letter 1


8 Nov 2024

Response to reviewer is provided in the attached file, please.

Attachment

Submitted filename: Rebuttal Letter to the editorPLOSone.docx

pone.0293790.s003.docx (17KB, docx)

Decision Letter 2

Adnan Ahmad Khan

25 Nov 2024

Self-reported illnesses in Thatta: Evidence from a rural and underdeveloped district in Sindh province, Pakistan

PONE-D-23-33013R2

Dear Dr. Malik,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Adnan Ahmad Khan

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Adnan Ahmad Khan

17 Dec 2024

PONE-D-23-33013R2

PLOS ONE

Dear Dr. Malik,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr Adnan Ahmad Khan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PONE-D-23-33013.pdf

    pone.0293790.s001.pdf (1.2MB, pdf)
    Attachment

    Submitted filename: ReviewreportPLOSone23.docx

    pone.0293790.s002.docx (28.2KB, docx)
    Attachment

    Submitted filename: Rebuttal Letter to the editorPLOSone.docx

    pone.0293790.s003.docx (17KB, docx)

    Data Availability Statement

    We cannot share data publicly because of legal and ethical restrictions. We have committed with the respondents of the survey at the time of singing consent form on confidentiality of personal information that are not to be shared with any third party. Same commitment has been made in the ethical review application." However, we can consider individual request for accessing data by writing to zaheer.habib@aku.edu Senior Manager, Data Management Unit, Community Health Sciences Department, Aga Khan University.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES